Vitamins B&C Kyowa Kirin Intravenous High Potency, Concentrate for Solution for Infusion
Find out about Vitamins B&C Kyowa Kirin Intravenous High Potency, Concentrate for Solution for Infusion (Vitamins B&C Kyowa Kirin IVHP), a rapid parenteral therapy for treating thiamine deficiency, including those related to alcohol misuse and malnutrition.1
Vitamins B&C Kyowa Kirin IVHP is indicated in adults and children for rapid therapy of severe depletion or malabsorption of the water soluble vitamins B and C:1
- Particularly in alcoholism, where a severe depletion of thiamine can lead to Wernicke’s encephalopathy
- After acute infections
- Post-operatively
- In psychiatric states
Adverse Events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse Events should also be reported to Kyowa Kirin International UK NewCo Ltd, known as Grünenthal Meds on +44 (0)1896 664000, email PVUK@grunenthalmeds.com
Click here for prescribing information.
Vitamins B&C Kyowa Kirin IVHP
-
INTRODUCTION
Find out more about treating patients with Vitamins B&C Kyowa Kirin IVHP: a parenteral therapy for treating thiamine deficiency that can help reverse the early changes in the brain caused by thiamine deficiency.1,6,7
-
MODE OF ACTION
Find out more about why Vitamins B&C Kyowa Kirin IVHP is critical in the treatment of thiamine deficiency for the prevention of alcohol related brain damage seen in Wernicke's encephalopathy.6
-
RESOURCES
Access resources, recommendations and guidance information, along with useful information on alcohol use and Wernicke's encephalopathy.
-
HOW TO PRESCRIBE
Guidance on how to prescribe Vitamins B&C Kyowa Kirin IVHP, including dosing, frequency and duration.
-
TOLERABILITY
Guidance on the most commonly reported side effects and adverse drug reactions.1
-
PRESCRIBING INFORMATION
Direction on prescribing Vitamins B&C Kyowa Kirin IVHP, covering information from dosing to precautions and contraindications.
-
References
1. Vitamins B&C Kyowa Kirin Intravenous High Potency, Concentrate for Solution for Infusion Summary of Product Characteristics.
2. Alcohol and brain damage in adults. With reference to high-risk groups. College report CR185. May 2014.
3. Alcohol related brain damage https://stepstocope.co.uk/wp-content/uploads/2019/09/Alcohol-Related-Brain-Damage-ABRD-FS1-1.pdf Last accessed June 2024.
4. Clinical Review - Alcohol-related brain damage https://www.gponline.com/clinical-review-alcohol-related-brain-damage/neurology/neurology/article/1140755 Last accessed June 2024.
5. Vasan S, Kumar A. Wernicke Encephalopathy. [Updated 2020 Nov 21]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
6. Thomson AD, et al. Alcohol Alcohol. 2002; 37(6): 513-521.
7. Thomson AD. Alcohol Alcohol. 2000; 35(1): 2-7.
8. Alcohol Use Disorders and Clinical Management of Alcohol Related Physical Complications [Clinical Guidance 100]. National Institute for Health and Care Excellence. Full Guidance June 2010 (updated April 2017).
KKI/GB/PAB/0260 June 2024